These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 37143385)

  • 1. Rapid high performance liquid chromatography method for erlotinib quantification in vitro: Application to study the effect of resveratrol on metabolism and cellular uptake of erlotinib.
    Zayed A; Al Hroot J; Mayyas A; Al-Husein B
    Fundam Clin Pharmacol; 2023 Oct; 37(5):983-993. PubMed ID: 37143385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous quantification of atorvastatin, erlotinib and OSI-420 in rat serum and liver microsomes using a novel liquid chromatography-mass spectrometry method.
    Rysz MA; Kinzi J; Schäfer AM; In-Albon K; Zürcher S; Schmidlin S; Seibert I; Schwardt O; Ricklin D; Meyer Zu Schwabedissen HE
    J Pharm Biomed Anal; 2023 Nov; 236():115716. PubMed ID: 37722165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erlotinib treatment induces cytochrome P450 3A activity in non-small cell lung cancer patients.
    Svedberg A; Vikingsson S; Vikström A; Hornstra N; Kentson M; Branden E; Koyi H; Bergman B; Gréen H
    Br J Clin Pharmacol; 2019 Aug; 85(8):1704-1709. PubMed ID: 30945322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of resveratrol on the pharmacokinetics of ticagrelor in vivo and in vitro.
    Wang P; Hu XX; Li YH; Gao NY; Chen GQ; Chen JL
    Can J Physiol Pharmacol; 2021 Aug; 99(8):821-826. PubMed ID: 33400617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic Induction of Erlotinib-Mediated Apoptosis by Resveratrol in Human Non-Small-Cell Lung Cancer Cells by Down-Regulating Survivin and Up-Regulating PUMA.
    Nie P; Hu W; Zhang T; Yang Y; Hou B; Zou Z
    Cell Physiol Biochem; 2015; 35(6):2255-71. PubMed ID: 25895606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Cytochrome P450 3A4 and 1A2 Phenotyping in Patients with Advanced Non-small-Cell Lung Cancer Receiving Erlotinib Treatment.
    Parra-Guillen ZP; Berger PB; Haschke M; Donzelli M; Winogradova D; Pfister B; Früh M; Gillessen S; Krähenbühl S; Kloft C; Joerger M
    Basic Clin Pharmacol Toxicol; 2017 Oct; 121(4):309-315. PubMed ID: 28444958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of Resveratrol on the pharmacokinetic profile of tofacitinib and the underlying mechanism.
    Ye Z; Hu J; Wang J; Liu YN; Hu GX; Xu RA
    Chem Biol Interact; 2023 Apr; 374():110398. PubMed ID: 36773832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochrome P450 3A selectively affects the pharmacokinetic interaction between erlotinib and docetaxel in rats.
    Qin X; Lu J; Wang P; Xu P; Liu M; Wang X
    Biochem Pharmacol; 2017 Nov; 143():129-139. PubMed ID: 28716728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of resveratrol on P-glycoprotein and cytochrome P450 3A in vitro and on pharmacokinetics of oral saquinavir in rats.
    Li J; Liu Y; Zhang J; Yu X; Wang X; Zhao L
    Drug Des Devel Ther; 2016; 10():3699-3706. PubMed ID: 27895462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substrate-dependent modulation of the catalytic activity of CYP3A by erlotinib.
    Dong PP; Fang ZZ; Zhang YY; Ge GB; Mao YX; Zhu LL; Qu YQ; Li W; Wang LM; Liu CX; Yang L
    Acta Pharmacol Sin; 2011 Mar; 32(3):399-407. PubMed ID: 21372830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential metabolism of gefitinib and erlotinib by human cytochrome P450 enzymes.
    Li J; Zhao M; He P; Hidalgo M; Baker SD
    Clin Cancer Res; 2007 Jun; 13(12):3731-7. PubMed ID: 17575239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid chromatography-tandem mass spectrometric assay for therapeutic drug monitoring of the EGFR inhibitors afatinib, erlotinib and osimertinib, the ALK inhibitor crizotinib and the VEGFR inhibitor nintedanib in human plasma from non-small cell lung cancer patients.
    Reis R; Labat L; Allard M; Boudou-Rouquette P; Chapron J; Bellesoeur A; Thomas-Schoemann A; Arrondeau J; Giraud F; Alexandre J; Vidal M; Goldwasser F; Blanchet B
    J Pharm Biomed Anal; 2018 Sep; 158():174-183. PubMed ID: 29883880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humanization of
    Rysz M; Schäfer AM; Paloumpis N; Kinzi J; Brecht K; Seibert I; Schmidlin S; In-Albon K; Ricklin D; Meyer Zu Schwabedissen HE
    J Pharmacol Exp Ther; 2024 Mar; 389(1):87-95. PubMed ID: 38448247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A High-Performance Liquid Chromatography with Photodiode Array Detection Method for Simultaneous Determination of Three Compounds Isolated from
    Keem MJ; Seo SW; Kim T; Jo BG; Kim SN; Yoon IS; Yang MH
    Nutrients; 2023 Sep; 15(18):. PubMed ID: 37764844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro determination of the CYP 3A4 activity in rat hepatic microsomes by liquid-phase extraction and HPLC-photodiode array detection.
    Baati T; Horcajada P; Gref R; Couvreur P; Serre C
    J Pharmacol Toxicol Methods; 2012 Jul; 66(1):29-34. PubMed ID: 22643301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The repression and reciprocal interaction of DNA methyltransferase 1 and specificity protein 1 contributes to the inhibition of MET expression by the combination of Chinese herbal medicine FZKA decoction and erlotinib.
    Zheng F; Zhao Y; Li X; Tang Q; Wu J; Wu W; Hann SS
    J Ethnopharmacol; 2019 Jul; 239():111928. PubMed ID: 31077779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic Pathway of Icotinib In Vitro: The Differential Roles of CYP3A4, CYP3A5, and CYP1A2 on Potential Pharmacokinetic Drug-Drug Interaction.
    Zhang T; Zhang K; Ma L; Li Z; Wang J; Zhang Y; Lu C; Zhu M; Zhuang X
    J Pharm Sci; 2018 Apr; 107(4):979-983. PubMed ID: 29247736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of resveratrol on pharmacokinetics of aripiprazole in vivo and in vitro.
    Zhan YY; Liang BQ; Li XY; Gu EM; Dai DP; Cai JP; Hu GX
    Xenobiotica; 2016; 46(5):439-44. PubMed ID: 26391142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exogenous Restoration of TUSC2 Expression Induces Responsiveness to Erlotinib in Wildtype Epidermal Growth Factor Receptor (EGFR) Lung Cancer Cells through Context Specific Pathways Resulting in Enhanced Therapeutic Efficacy.
    Dai B; Yan S; Lara-Guerra H; Kawashima H; Sakai R; Jayachandran G; Majidi M; Mehran R; Wang J; Bekele BN; Baladandayuthapani V; Yoo SY; Wang Y; Ying J; Meng F; Ji L; Roth JA
    PLoS One; 2015; 10(6):e0123967. PubMed ID: 26053020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro ketamine CYP3A-mediated metabolism study using mammalian liver S9 fractions, cDNA expressed enzymes and liquid chromatography tandem mass spectrometry.
    Santamaria R; Pailleux F; Beaudry F
    Biomed Chromatogr; 2014 Dec; 28(12):1660-9. PubMed ID: 24729431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.